Corrigendum: Role of ARRB1 in prognosis and immunotherapy: a pan-cancer analysis

Corrigendum: Role of ARRB1 in prognosis and immunotherapy: a pan-cancer analysis

Saved in:

Bibliographic Details
Main Authors:	Yingquan Ye, Haili Jiang, Yue Wu, Gaoxiang Wang, Yi Huang, Weijie Sun, Mei Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Molecular Biosciences
Subjects:	ARRB1 pan-cancer prognosis tumor immunity biomarker
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2025.1577764/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis
by: Yingquan Ye, et al.
Published: (2022-09-01)

β-suppressor protein 1 (ARRB1)-△exon13 modulates the progression of glioblastoma via combination with glycolysis-related proteins
by: Zi-Long Wei, et al.
Published: (2025-06-01)

Microglia TRPC1 SUMOylation drives neuroinflammation after stroke by modulating NLRP3 activity via increasing TRPC1 interaction with ARRB2
by: Huinan Zhang, et al.
Published: (2025-03-01)

Comprehensive pan-cancer analysis indicates UCHL5 as a novel cancer biomarker and promotes cervical cancer progression through the Wnt signaling pathway
by: Lingling Bao, et al.
Published: (2024-12-01)

GSDMD is a novel predictive biomarker for immunotherapy response: in the pan-cancer and single cell landscapes
by: Li Juan Huang, et al.
Published: (2025-05-01)

A pan-cancer analysis: predictive role of ZNF32 in cancer prognosis and immunotherapy response
by: Minghan Li, et al.
Published: (2025-01-01)

NCBP2 predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis
by: Shichao Li, et al.
Published: (2025-03-01)

Integrative pan-cancer analysis and experiment validation identified GLS as a biomarker in tumor progression, prognosis, immune microenvironment, and immunotherapy
by: Dongming Li, et al.
Published: (2025-01-01)

Magnesium-related gene ITGAL: a key immunotherapy predictor and prognostic biomarker in pan-cancer
by: Fengjie Lin, et al.
Published: (2024-11-01)

Pan-cancer analysis and single-cell analysis identifies the CENPN as a biomarker for survival prognosis and immunotherapy
by: Nie Zhang, et al.
Published: (2025-01-01)

Pan-cancer analysis identifies the correlations of Thymosin Beta 10 with predicting prognosis and immunotherapy response
by: Zhanzhan Li, et al.
Published: (2023-05-01)

Correction: Pan-cancer analysis identifies the correlations of Thymosin Beta 10 with predicting prognosis and immunotherapy response
by: Zhanzhan Li, et al.
Published: (2025-08-01)

Pan-immune-inflammation value is associated with poor prognosis in patients undergoing peritoneal dialysis
by: Fengping Zhang, et al.
Published: (2023-12-01)

Pan-Cancer Analysis of Disulfidptosis-Related Genes Affecting Prognosis and Tumor Microenvironment
by: Jingyang SUN, et al.
Published: (2025-01-01)

NEK2 is a potential pan-cancer biomarker and immunotherapy target
by: Lanyue Zhang, et al.
Published: (2024-11-01)

Pan-immune-inflammation value and its association with all-cause and cause-specific mortality in the general population: a nationwide cohort study
by: Ye Zhang, et al.
Published: (2025-04-01)

Comprehensive analysis of single-cell and bulk RNA sequencing data reveals an EGFR signature for predicting immunotherapy response and prognosis in pan-cancer
by: Changchun Ye, et al.
Published: (2025-06-01)

Exploring the potential value of SRC in pan cancer based on bioinformatics methods
by: Liyin Huang, et al.
Published: (2025-07-01)

Pan-cancer analysis reveals dual roles of HES6 in cancer immunity and prognosis
by: Ying Sun, et al.
Published: (2025-06-01)

Multi-omics analysis identifies UBA family as potential pan-cancer biomarkers for tumor prognosis and immune microenvironment infiltration
by: Haibin Wang, et al.
Published: (2025-02-01)

iMLGAM: Integrated Machine Learning and Genetic Algorithm‐driven Multiomics analysis for pan‐cancer immunotherapy response prediction
by: Bicheng Ye, et al.
Published: (2025-04-01)

NOX4 as an emerging prognostic and immunological biomarker across pan-cancer analyses
by: Yusheng Liu, et al.
Published: (2025-05-01)

Chaperonin containing TCP1 subunit 5 as a novel pan-cancer prognostic biomarker for tumor stemness and immunotherapy response: insights from multi-omics data, integrated machine learning, and experimental validation
by: Jiajun Li, et al.
Published: (2025-05-01)

Unravelling the association between metformin and pan-cancers: Mendelian randomization combined with NHANES database analysis
by: Jia-Cheng Xiang, et al.
Published: (2025-03-01)

APOA1 promotes tumor proliferation and migration and may be a potential pan-cancer biomarker and immunotherapy target
by: Peiyi Xu, et al.
Published: (2025-05-01)

Nomogram based on pan-immune-inflammation value to predict short-term prognosis in spontaneous intracerebral hemorrhage
by: Shuai Wang, et al.
Published: (2025-08-01)

Integrating necroptosis into pan-cancer immunotherapy: a new era of personalized treatment
by: Yan Gao, et al.
Published: (2024-12-01)

NSUN6 expression correlates with prognosis and immune infiltration in human cancers based on pan-cancer analysis
by: Jie Gao, et al.
Published: (2025-07-01)

Islam and the Pan-Abrahamic Problem
by: Joshua R. Sijuwade
Published: (2025-01-01)

Autonomic nervous system development-related signature as a novel predictive biomarker for immunotherapy in pan-cancers
by: Cunen Wu, et al.
Published: (2025-07-01)

Preliminary analysis of association of m<sup>7</sup>G methyltransferase 1 with pan-cancer prognosis and immune infiltration
by: CHENG Wenli, et al.
Published: (2024-07-01)

ZNF385B as a potential prognostic and immunotherapy biomarker in ovarian cancer: insights from pan-cancer analysis
by: Hang Yu, et al.
Published: (2025-08-01)

Comprehensive pan-cancer analysis and experimental validation reveal FCHSD1 as a potential biomarker for diagnosis, immune infiltration, and prognosis
by: Ming Liu, et al.
Published: (2025-06-01)

Pan-cancer analysis identifies ADAM12 as a prognostic biomarker and indicator of immune infiltration in glioma
by: Peng Lv, et al.
Published: (2025-02-01)

SERPINA1 is a new frontier in cancer immunotherapy and drug targeting by pan-cancer analysis
by: Chen Fu, et al.
Published: (2025-06-01)

CD99 is a potential diagnostic and immunological biomarker in pan-cancer
by: Juntao Jiang, et al.
Published: (2025-08-01)

Pan-cancer characterization of m6A-mediated regulation of T cell exhaustion dynamics and clinical relevancies in human cancers
by: Weiping Ji, et al.
Published: (2025-03-01)

DPH2 is a biomarker associated with cell death, immunity and prognosis based on pan-cancer analysis
by: Maolin Xiao, et al.
Published: (2025-02-01)

The Role of PLIN3 in Prognosis and Tumor-Associated Macrophage Infiltration: A Pan-Cancer Analysis
by: Yang S, et al.
Published: (2025-03-01)

MiR-326: Role and significance in brain cancers
by: Zaira Spinello, et al.
Published: (2025-06-01)